Hector Antonio, M.D.

Dr. Antonio López Rivera earned his medical degree at the University of Guadalajara, Mexico.

With a strong foundation in primary care, emergency medicine, and clinical review, he has developed a keen ability to assess, optimize, and personalize treatment strategies. His deep commitment to patient-centered care drives him to go beyond conventional medicine, ensuring that individuals receive scientifically grounded, innovative therapies that prioritize their well-being.

Dr. López Rivera believes that oncology should focus on the whole patient, not just the disease. His meticulous approach to treatment evaluation, combined with his expertise in regulatory compliance and global health perspectives, allows him to bridge cutting-edge science with compassionate care.

Through ongoing education, research, and collaboration, he strengthens Immunocine’s mission to revolutionize cancer treatment with precision medicine.”